Tags : University of Texas

Boehringer Ingelheim Signs a Multi-Year Agreement with University of Texas

Shots: The companies collaborated to establish a Virtual Research and Development Center, enabling data sharing and analysis and focusing on research of therapies for multiple types of cancers, including gastrointestinal and lung cancers The focus of the agreement is to combine novel therapies from Boehringer’s oncology pipeline with patient-driven drug-development capabilities of MD Anderson’s Therapeutics […]Read More